Search Results

Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials September 2020 Abstract Psilocybin is a naturally occurring tryptamine known for its psychedelic The aim of this work was to perform a systematic review with meta-analysis of clinical trials to assess

Methods: In this paper we performed a systematic review of the clinical trials conducted so far regarding The eligibility criteria included clinical trials that assessed psilocybin's potential therapeutic effects Research on depression showed the most solid evidence, supported by 3 randomized controlled trials.

In the last decade, a plethora of preclinical and clinical studies have confirmed the efficacy of ketamine

For mood and anxiety disorders, three controlled trials have suggested that psilocybin may decrease symptoms Description: This randomized, double-blind, cross-over trial investigated the effects of a very low Mushroom Research Institute Date: September 2020 Keywords: anxiety, clinical trials, depression, meta-analysis trials to assess the therapeutic effects and safety of psilocybin on those medical conditions. Description: In this paper we performed a systematic review of the clinical trials conducted so far regarding